Lesaka Technologies heads into its May 7 earnings print with a clear insider conviction signal sitting in contrast to a stock that remains under pressure near multi-year lows.
The standout data point heading into the report is insider buying. Executive Chairman Ali Mazanderani purchased 32,000 shares at $4.69 on March 4, then added a further 91,423 shares at $4.36 on February 9 — a combined outlay of roughly $549,000. Net insider buying across the past 90 days totals a substantial $9.6 million across nearly 1.9 million net shares. That is an unusually heavy commitment from the top of the house at a company trading around $4.90, and it stands directly against a pattern of small-lot selling from a board-represented private equity holder, whose transactions ran into the low thousands of dollars — noise rather than a directional signal.
The broader setup is muted rather than charged. Short interest is minimal at just 0.36% of the free float, and the borrow market reflects that indifference — cost to borrow runs at roughly 2% annualised, a near-standard rate, while availability remains ample. The ORTEX short score of 34.6 sits in the lower half of the universe. Options activity tells an almost identical story: the put/call ratio has been effectively zero for weeks, well below even its modest 20-day average of 0.03, indicating that neither directional hedgers nor speculative put buyers have taken meaningful positions ahead of the release.
The fundamental picture gives investors something to focus on. Consensus estimates point to revenue of roughly $681 million and EBITDA near $72 million, with net income barely above breakeven at an estimated $1.1 million — a razor-thin margin profile for a payments infrastructure business. Analyst coverage is sparse and all data on record is significantly stale, so there is no current Street consensus to calibrate against. The institutional base is concentrated: Value Capital Partners holds nearly a fifth of shares, the International Finance Corporation another 10%, and Goldman Sachs and Morgan Stanley together account for around 12%. None of those top holders meaningfully changed their positions in recent months, suggesting the register is relatively sticky heading in.
The print will test whether the thin profitability underpinning those insider purchases is beginning to widen — and whether management's conviction at sub-$5 translates into a margin trajectory the market can price.
See the live data behind this article on ORTEX.
Open LSAK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
